INCY Max Pain $125 (Oct 16 Exp) · Dark Pool 37.1% — Free
Undercurrent · Money-flow snapshot
INCY Max Pain, Dark Pool & Options Flow
INCY max pain for the Oct 16, 2026 expiry is $125, from the Fri Oct 2 options chain. The last price, $114.13, is 8.7% below it. Call wall $135 · put floor $110.
What the institutional money is doing on INCY right now — dark pool, options positioning, and where the news and the money disagree. Free.
The money right now
Dark pool share
37.1% (market avg 49%)
Dark pool volume vs its norm
1.3×
Short share of that
63.6% (norm 64%)
Price
$114.13
Max pain
$125
Oct 16 exp
Call wall
$135
Oct 16 exp
Put floor
$110
Oct 16 exp
Put/Call ratio
0.51
Squeeze pressure
10
Dark pool share: Off-exchange volume ran 1.3× its norm — and only 64% vs a 64% norm of it was short
Off-exchange prints never touch the public book, so they move size without moving the quote. That is the point of using them. Volume rose while the short share stayed low, meaning most of that extra size was not sell-side. This is what quiet accumulation looks like on the tape.
Source: FINRA · Mon 10/5 close
What it means: INCY shows mixed signals: standing positions favor calls over puts, but recent trading volume leaned heavily toward puts (3.13× more puts than calls traded), suggesting traders are hedging or taking defensive positions despite the bullish open interest structure. Off-exchange activity is elevated at 1.34× normal volume with short-heavy positioning (63.6% short, in line with the 20-day norm), indicating institutional accumulation working large orders away from the public book without moving the quote.
News vs the money
INCY vs TECH: Which biotech stock offers better value?
Standing positions favor upside (more calls than puts), but the latest trading session saw traders buy 3× more downside protection (puts) than upside calls, a divergence suggesting caution despite the bullish open interest backdrop.
Zacks Investment Research · 09/30
Mirum wins FDA approval for rare bone-disorder drug Atebrioz
No new option positions were opened around this approval news; the standing call-heavy structure and elevated off-exchange accumulation suggest institutions may have already positioned ahead of the announcement.
Zacks Investment Research · 09/28
MiniMed appoints new General Counsel and Corporate Secretary
This is a personnel announcement unrelated to INCY; no money signals are present.
PRNewsWire · 09/28
⚡ DIVERGENCEIncyte and Mirum announce FDA approval of Atebrioz for fibrodysplasia ossificans progressiva
Standing positions remain call-heavy (more calls than puts), but the latest session's trading volume swung sharply toward puts (3.13× ratio), signaling that traders are hedging against downside despite the positive news—a classic divergence between headline optimism and positioning caution.
Business Wire · 09/25
Incyte presents inflammation and autoimmunity research at European dermatology congress
No new option positions opened; the standing call-heavy structure persists, but elevated off-exchange short activity (63.6%, normal for this name) combined with defensive put trading in the latest session suggests institutions are accumulating quietly while traders hedge—a patient, cautious posture.
A divergence is when the news narrative and the institutional money flow point in opposite directions — a bearish headline while large call premium is bought, or heavy dark-pool selling under a bullish story. It signals the crowd and the desks may disagree.
How to read these numbers
Dark-pool volume — The share of trading executed off-exchange, at wholesalers and dark pools. About half of all US share volume prints there on an ordinary day, so the level by itself says almost nothing. What carries information is the distance from this name’s own recent norm, and whether the off-exchange size ran above its usual.
Off-exchange short share — How much of that off-exchange volume was sold short. The median across all listed names is about 49%, because wholesalers filling retail buy orders sell short and cover later. A reading near half is plumbing, not a bearish vote — compare it to the same name’s own 20-day norm.
Max pain — The price where the most options expire worthless — positioning often gravitates toward it near expiry.
Call wall / Put floor — Strikes with the heaviest call/put open interest — they often act as short-term resistance and support.